Gunderson Dettmer proudly celebrates the 2024 Global Diversity Awareness Month this October, reflecting on a year of meaningful engagement with diverse communities. From honoring Asian American and Pacific Islander Heritage Month with a team gathering in Chinatown to celebrating Black History Month by showcasing the achievements of Black clients, the firm’s goal is clear: to foster connections. In our inaugural message for Global Diversity Awareness Month, five partners representing the firm’s Diversity & Inclusion Committee and our nine affinity groups share their stories and insights, illustrating how these groups help foster bonds in a demanding legal environment. The message also features authentic perspectives from professional staff and associate conveners, who emphasize the critical role of representation and creating inclusive spaces where everyone feels valued, heard and supported, regardless of their race, gender, cultural backgrounds and past experiences. Our differences unite us, and it is through this diversity that we become a stronger, more resilient firm. Thank you to our amazing attorneys and professional staff members who participated in our video. Together, we celebrate our differences in unity. Brian Huber, Melissa Marks, Jennifer Sayles Okorn, Marna Pattaropong, Natalie Pierce, Wesley Watts, Maurice Osei, Viviane Scott, Men-Lei Carrington Learn more here. https://lnkd.in/g3TTYwrM #GlobalDiversityAwarenessMonth #Diversity #Celebrations
Gunderson Dettmer
Law Practice
Redwood City, California 17,717 followers
We are the preeminent international law firm with an exclusive focus on the innovation economy.
About us
Gunderson Dettmer is the preeminent international law firm with an exclusive focus on the innovation economy. We serve market-leading venture capital and growth equity investors and pioneering private companies through inception, growth and maturity, as well as the groundbreaking public companies that result from the global venture capital ecosystem. With an exclusive focus on rapidly evolving industries, we attract talent that is hungry to be a part of the innovation economy. We have unmatched experience and technical acumen that allows us to predict, prioritize, and produce strategic solutions for our clients at every business phase. With scalable capabilities and high-touch service, and through trusted relationships and uniquely pragmatic advice, we propel our clients toward what’s next. For more information please visit http://www.gunder.com.
- Website
-
http://www.gunder.com
External link for Gunderson Dettmer
- Industry
- Law Practice
- Company size
- 201-500 employees
- Headquarters
- Redwood City, California
- Type
- Partnership
- Founded
- 1995
- Specialties
- Business-oriented legal services for emerging growth companies and the venture capital industry that supports them.
Locations
Employees at Gunderson Dettmer
Updates
-
Gunderson Dettmer teamed up with Harlem Capital in San Francisco to host a dinner that united diverse leaders in the tech industry. The event brought together diverse founders and C-suite executives leading Series B+ and growth stage companies, to celebrate shared experiences, forge meaningful connections, and collectively shape the future of diverse leadership in tech. Gunderson partner Randall Clark and associate Andrew Person were in attendance. #Diversity #Tech #SanFrancisco #Founders
-
Gunderson Dettmer reposted this
ACC San Diego - Association of Corporate Counsel has two great in-person events next week! Join us on October 15th for Trivia Night, presented by Pettit Kohn Ingrassia Lutz & Dolin PC, and JurisBREWdence on October 16th, presented by Gunderson Dettmer! Network with your colleagues and enjoy light bites and cocktails. Register at https://lnkd.in/gTi-afM
-
Coming off the success of the 2024 NYC Summit, Gunderson Dettmer partnered up with Primary Venture Partners to host an intimate Founders Open House at Primary HQ. Gunderson partners Melissa Marks and Hilary Adams and associates Sam Feldman and Madeline Koo joined the event which provided a networking scene for those getting started on their entrepreneurial path. Thank you to Gaby Lorenzi and the team at Primary for an amazing evening!
-
Gunderson Dettmer reposted this
🎉It’s an exciting day at Recast! 🎉 We’re so incredibly proud to unveil our second cohort of the Accelerate Program. These outstanding emerging fund managers are set to make a significant impact across the ecosystem and we couldn’t be more excited to support their journey! ⭐ We’re honored to have the following funds in our second cohort: ⭐ AIN Ventures Alante Capital Alinea Ventures Altari Ventures Apprentis Ventures BAG Ventures LLP Capital F Coalition Operators Dorm Room Fund FJOR FoundersEdge Frankenbuild Ventures FullCircle Hometeam Ventures Iron Prairie Ventures Moth Fund Mother Ventures Phenomenal Ventures Planeteer Capital Primer Ventures Recall Capital Rogue Women's Fund Sarah Smith Fund Sugar Free Capital Type Capital (GPs linked in comments) Please join us in congratulating this crew! We look forward to what the next year has in store! 👏 Thank you to our committee of LPs who assisted in the selection process. We also extend our gratitude to our partners and sponsors who have supported the Accelerate Program this year: Pivotal Ventures, Gunderson Dettmer, Strut Consulting, Antares Capital LP, Aumni, Banc of California, Citizens, Cornerstone Fund Services, Frank, Rimerman + Co. LLP, Sydecar, and Mercury. To learn more about the Accelerate Program and the second cohort, check out the press release below. https://lnkd.in/gqAaaZQY
-
Gunderson Dettmer is proud to continue its sponsorship of Recast Capital by supporting the second cohort of Recast Accelerate, a catalytic program designed to drive the success of women and nonbinary-led, early stage US funds in venture capital. The Fall 2024 cohort hosts GPs from 25 funds; 100% of the funds have at least one GP who identifies as a woman or non-binary, 28% have at least one GP who is Black, 20% Asian, 4% LatinX, 12% LGBTQIA+, and 32% first generation US citizens. Sectors of fund focus vary across verticals including, but not limited to, ClimateTech, Artificial Intelligence, Enterprise SaaS, FinTech, and Health and Wellness. Recast Accelerate launched in early 2023 with the intent to help more diverse managers successfully raise and run institutional-quality funds. Accelerate provides access to Recast's established Enablement Program, including key educational content, professional development and community-building resources, complimentary executive coaching, and $100k to be leveraged in support of each fund's backend operations. Learn more here. https://prn.to/4dCvTaR #Recast #Cohort #AcceleratorProgram #Diversity
Recast Capital Announces Second Cohort for the Accelerate Program
prnewswire.com
-
Congratulations to David Baker, co-founder of Gunderson Dettmer client Xaira Therapeutics, on being awarded the Nobel Prize in Chemistry. David, along with Demis Hassabis and John Jumper, received this prestigious honor for their groundbreaking work in discovering powerful techniques to predict and design novel proteins — the fundamental building blocks of life. We are proud to work with individuals who are redefining the future of science and innovation Learn more here. https://bit.ly/4eCLRmn #NobelPrize #Awards #XairaTherapeutics
Nobel Prize in chemistry awarded to 3 scientists for work on proteins, building blocks of life
apnews.com
-
Congratulations to Gunderson client Carta Healthcare on earning first-place Gold recognition for “Best Use of AI in Healthcare” in the 2024 Merit Awards for Technology. We are proud to work with companies that continue to push the boundaries of AI.
We’re honored to have earned first-place Gold recognition for “Best Use of AI in Healthcare” in the 2024 Merit Awards for Technology. “It is certainly an honor to be selected from among so many AI-powered health-tech solutions as the best solution in the market, which is a testament to the hard work and dedication of the many data scientists, clinicians and other team members, who since 2017, have been developing and improving the Carta Healthcare platform,” said Carta Healthcare CEO Brent Dover. “We are also grateful for recognitions like the Merit Awards that help raise awareness of how health systems can trust our AI-powered solution to automate clinical data abstraction, making abstraction faster and higher quality, at a much lower cost than manual efforts today.” Learn more about Carta Healthcare and the Merit Awards: https://bit.ly/3zYyz4z | #MeritAwards #MeritForTechnology #TechnologyAwards #ClinicalDataAbstraction
-
With over 1 million digital accounts created and over 660 employees across Brazil, Gunderson Dettmer client Asaas provides a complete digital account for all types and sizes of businesses, automating financial management processes, increasing productivity, and reducing bureaucracy. Congratulations to the company on its Series C financing led by BOND that will be used to expand its operations, accelerate research and development efforts, and inorganic growth through new acquisitions. The Gunderson Dettmer deal team was led by Adan Canizales Muller and included Katie Gardner, Lily Kim, Eduarda Tavares, Luiz Arthur (Tuca) Bihari, Arthur Dalmarco and David K. Learn more here. https://bit.ly/3zFuRNq #LatAm #Asaas #Fintech #SeriesC
-
Gunderson Dettmer client City Therapeutics announces its launch with a $135M Series A led by ARCH Venture Partners. City Therapeutics aims to harness next-generation engineering of small interfering RNAs (siRNAs) – the “trigger” molecules that mediate RNAi – to build a robust and sustainable product engine and expand the therapeutic reach of RNAi-based medicines. Co-founder and executive chair John Maraganore said, “We see the potential for RNAi to emerge as the next major category of high-impact medicines, rivaling if not exceeding the success of monoclonal antibodies. New innovation is needed to realize this future, and we believe City Therapeutics can lead this next chapter." Learn more here. https://bit.ly/3NhzBM2 #CityTherapeutics #RNAs #LifeSciences